Novel study shows impact of staph prevention measures in NICU CHICAGO — Using genome sequencing, researchers found that the infection-prevention practices of using an antibiotic ointment and antiseptic wash in the NICU greatly reduced the spread of staph bacteria. “Our findings are the first to use whole genome sequencing to show that Staphylococcus aureus screening and targeted decolonization reduce transmission among infants in a NICU,”

Researcher Sarah Hochman said her team’s study shows “direct impact” of 🧬genome sequencing tracking #staph in the #NICU and ultimately limiting its spread. #SHEA2026

vist.ly/4ycsp

Novel study shows impact of staph prevention measures in NICU CHICAGO — Using genome sequencing, researchers found that the infection-prevention practices of using an antibiotic ointment and antiseptic wash in the NICU greatly reduced the spread of staph bacteria. “Our findings are the first to use whole genome sequencing to show that Staphylococcus aureus screening and targeted decolonization reduce transmission among infants in a NICU,”

📢Researchers presented their study at #SHEA2026, finding that with 🧬genome sequencing they could prove that infection-prevention practices in the #NICU greatly reduced the spread of #staph.

vist.ly/4yap2

RSV vaccine protection wanes for some nursing home residents CHICAGO — A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for illness, although protection waned over time for some.Researchers measured the protective impact of Abrysvo, Pfizer’s RSV vaccine, among 15,078 residents living in Veterans Health Administration nursing homes over the course of two seasons.

💉Researchers presented their study at #SHEA2026 that showed #RSV vaccine protection remained steady for younger nursing home residents while protection dipped for older ones. 🦠

vist.ly/4y4fj

Sharing our work on risk factors associated with progression of Candida auris colonization to invasive infection @sheaepi.bsky.social #SHEA2026 #CandidaAuris #SHEASpring2026

RSV vaccine protection wanes for some nursing home residents CHICAGO — A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for illness, although protection waned over time for some.Researchers measured the protective impact of Abrysvo, Pfizer’s RSV vaccine, among 15,078 residents living in Veterans Health Administration nursing homes over the course of two seasons.

💉📢Researchers, who presented their findings at #SHEA2026, measured the protective impact of #RSV vaccine #Abrysvo from Pfizer among 15,078 nursing-home residents.

vist.ly/4xxw3

RSV vaccine protection wanes for some nursing home residents CHICAGO — A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for illness, although protection waned over time for some.Researchers measured the protective impact of Abrysvo, Pfizer’s RSV vaccine, among 15,078 residents living in Veterans Health Administration nursing homes over the course of two seasons.

🚨A study presented at #SHEA2026 revealed that an #RSVvaccine 💉 showed a “meaningful reduction” of illness risk. Read here ⬇️

vist.ly/4xu9h